mycophenolate mofetil + corticosteroids

Mycophenolate mofetil (MMF) combined with corticosteroids is a therapeutic combination used primarily for immunosuppression in various conditions. This combination leverages the complementary mechanisms of both drugs to achieve enhanced immunosuppressive effects while potentially allowing for reduced corticosteroid dosing. ### Mechanism of Action Mycophenolate mofetil is a prodrug that is rapidly converted to its active metabolite, mycophenolic acid (MPA), after oral administration. MPA works by selectively inhibiting inosine monophosphate dehydrogenase (IMPDH), an enzyme crucial for de novo purine synthesis[5][6][8]. This inhibition particularly affects T and B lymphocytes, which rely heavily on this pathway for proliferation, while other cell types can utilize alternative salvage pathways[8]. The combination with corticosteroids provides complementary immunosuppressive effects. Corticosteroids have broad anti-inflammatory and immunosuppressive properties, affecting multiple immune cell types and inflammatory pathways. Together, these medications provide potent immunosuppression while potentially allowing for lower doses of corticosteroids, reducing steroid-related side effects[1][2]. ### Clinical Applications This combination therapy has been studied and used in various conditions: 1. **Transplant Medicine**: Prevention of organ rejection in kidney, heart, and liver transplants[5]. 2. **Nephrology**: - Treatment of Henoch-Schönlein purpura nephritis (HSPN)[1] - Management of IgA nephropathy (IgAN)[9] 3. **Gastroenterology**: - Management of immune checkpoint inhibitor-induced colitis[2] - Treatment of Crohn's disease, particularly in corticosteroid-dependent patients[7] 4. **Rheumatology**: - Treatment of retroperitoneal fibrosis[3] 5. **Hematology**: - Treatment of acute graft-versus-host disease (GVHD)[4] 6. **Dermatology**: - Management of various immune-mediated skin diseases[6][8] - Treatment of psoriasis[8] ### Efficacy and Safety Clinical studies have shown varying results depending on the condition being treated: - In HSPN, MMF with low-dose prednisone showed similar remission rates to full-dose corticosteroids alone (77.8% vs 80.8%) but with fewer side effects (48.1% vs 76.9%)[1]. - For immune checkpoint inhibitor-induced colitis, MMF alongside high-dose corticosteroids may help reduce corticosteroid exposure without precipitating colitis flares[2]. - In acute GVHD, a phase 3 trial found that adding MMF to corticosteroids did not improve GVHD-free survival compared to corticosteroids alone[4]. - For IgA nephropathy, MMF combined with low-dose prednisone has shown effectiveness and safety in long-term follow-up[9]. ### Dosing Considerations Dosing varies by indication, but common regimens include: - MMF 1-2g daily (often divided into twice-daily dosing) combined with varying doses of corticosteroids, typically starting at higher doses and tapering over time[1][2][7]. - For some conditions, MMF allows for lower corticosteroid doses while maintaining efficacy, which can reduce steroid-related adverse effects[1][2]. ### Drug Interactions Important drug interactions to consider: - MMF should not be combined with azathioprine as both block purine synthesis through the same pathway[6]. - Drugs that affect MMF levels include: - Increased levels: acyclovir, ganciclovir, probenecid - Decreased absorption/bioavailability: antacids containing aluminum and magnesium, ferrous sulfate, metronidazole, fluoroquinolones - Decreased levels: cholestyramine (inhibits enterohepatic recirculation) - Competition for plasma albumin binding: salicylates, furosemide[6] ### Adverse Effects Common adverse effects include: - Gastrointestinal symptoms - Hematological abnormalities (leukopenia, neutropenia) - Increased risk of infections The combination therapy aims to reduce corticosteroid-related side effects while maintaining immunosuppressive efficacy[1][2].

Brand names

CellCept + steroidMyhibbin + steroid

Other names

MMF + steroid